Riskpilot← Back to searchSign inGet full accessPer Åkefeldt Psykiatri AB
ABActiveOrg 5590692231Korsvägen 3Medical specialists activities · NACE 8622Est. 20161 employees
Revenue 2024
SEK 2,2M
+5% vs 2023
EBITDA margin
29.5%
-28% vs 2023
Equity ratio
92.7%
Financial strength
Net profit 2024
SEK 520K
-29% vs 2023
| Revenue | SEK 2,2M | +5% |
| EBITDA | SEK 662K | -28% |
| Net profit | SEK 520K | -29% |
| Total assets | SEK 1,6M | -27% |
| Equity | SEK 1,4M | -21% |
| Employees | 1 | — |
Legal name
Per Åkefeldt Psykiatri AB
Org number
5590692231
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 juli 2016
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva kliniskt arbete, undervisning och handledning inom psykiatri och psykoterapi.
Address
Korsvägen 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 372 | 1 812 | 1 820 | 2 145 | 2 245 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 480 | 703 | 872 | 919 | 662 |
| Depreciation & amort. | −270 | −195 | −0 | −0 | −0 |
| EBIT | 210 | 508 | 872 | 919 | 662 |
| Net financials | −1 | −1 | — | −1 | −6 |
| Profit before tax | 210 | 566 | 872 | 918 | 656 |
| Tax | −45 | −117 | −180 | −189 | −136 |
| Net profit | 165 | 449 | 692 | 729 | 520 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 940 | 1 036 | 1 371 | 2 116 | 1 555 |
| Equity | 461 | 909 | 1 102 | 1 831 | 1 441 |
| Long-term debt | 320 | 0 | 0 | 0 | 0 |
| Short-term debt | 101 | 127 | 270 | 285 | 114 |
| Total debt | 421 | 127 | 270 | 285 | 114 |
EBITDA margin
29.5%
This company
15.8%
Market median
+87% vs market
20202024
Equity ratio
92.7%
This company
38.2%
Market median
+143% vs market
20202024
Return on equity
36.1%
This company
18.4%
Market median
+96% vs market
20202024
Net profit margin
23.2%
This company
8.1%
Market median
+186% vs market
20202024
Asset turnover
1.44×
This company
1.12×
Market median
+29% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
UT Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Per Åkefeldt Psykiatri AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Thomas Andresen | Audit | 0 companies |
| Selma Magdalena Cecilia Åkefeldt | Deputy Board Member | 0 companies |
| Per Sven Albert Åkefeldt | Board of Directors | 0 companies |